Is Instantaneous Flow Reserve (IFR) measurement reliable in patients with Heart Failure with Reduced Ejection Fraction (HFrEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IFR Measurement Reliability in HFrEF Patients

The provided evidence does not address the reliability of Instantaneous Flow Reserve (IFR) measurement in patients with HFrEF, making it impossible to provide a guideline-based recommendation on this specific question.

Evidence Gap Analysis

The available guidelines and research focus on:

  • Diagnostic evaluation of HFrEF includes echocardiography, natriuretic peptides, coronary angiography, and stress testing, but IFR is not mentioned 1

  • Coronary assessment in HFrEF guidelines recommend coronary arteriography for patients with angina or significant ischemia, and stress imaging for detecting myocardial ischemia and viability 1

  • Distinguishing ischemic from non-ischemic HFrEF utilizes stress echocardiography, SPECT/CT MPI, PET imaging, and cardiac MRI with late gadolinium enhancement, but IFR is not discussed 1

Clinical Context for Coronary Evaluation in HFrEF

When assessing coronary disease in HFrEF patients:

  • Coronary angiography is Class I recommendation for HFrEF patients presenting with angina or significant ischemia unless not eligible for revascularization 1

  • Noninvasive stress imaging is Class IIa for detecting myocardial ischemia and viability in HFrEF patients with known coronary disease but without angina 1

  • Cardiac MRI with late gadolinium enhancement demonstrates high diagnostic accuracy (97%) for detecting ischemic myocardial damage in new-onset HFrEF, comparable to coronary angiography 1

Important Caveats

The absence of IFR in HFrEF guidelines may reflect:

  • Limited validation studies in the HFrEF population specifically
  • Potential concerns about microvascular dysfunction affecting pressure-flow relationships in failing myocardium
  • Preference for established modalities with proven outcomes data in this population 1

General considerations for invasive coronary assessment in HFrEF should account for elevated filling pressures, altered hemodynamics, and the potential impact on pressure-derived indices 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the best management approach for a 79-year-old male with Type 2 Diabetes Mellitus (DM II), atrial fibrillation (a fib), and Heart Failure with Reduced Ejection Fraction (HFrEF) who has a 6cm diameter and 11cm length abdominal aortic aneurysm (AAA)?
In a 58-year-old patient with progressive dyspnea, paroxysmal nocturnal dyspnea, anterior wall hypokinesia and left ventricular ejection fraction of 30%, which is the next best investigation: myocardial perfusion scan, CT angiography, coronary angiography, or chest X‑ray?
What is the diagnosis and management for an elderly male presenting with chest pain, breathing difficulty, ST segment depression on ECG, and reduced stroke volume?
What antibiotics are suitable for a patient with cardiomyopathy and a history of heart failure with reduced ejection fraction?
What is the best management approach for a 63-year-old male with chest heaviness, hypotension, on low-dose noradrenaline infusion, and an ejection fraction of 20%?
What could be causing internal tremor feelings, decreased endurance, and blurred vision?
Can celiac disease be treated?
What are the society guidelines for managing ventilator-associated pneumonia (VAP) caused by colonized bacteria?
What are the most critical Human Papillomavirus (HPV) genotypes to be aware of?
What are the most effective treatment options for endometriosis, including their risks and benefits?
Can I give diclofenac (Nonsteroidal Anti-Inflammatory Drug (NSAID)) to a patient with impaired renal function (dialysis) for gout?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.